SCHEMBL13507865

SCHEMBL13507865

c1ccc2cc(N(c3ccc4ccccc4c3)c3ccc4c(c3)sc3c5sc6cc(N(c7ccc8ccccc8c7)c7ccc8ccccc8c7)ccc6c5c5ccccc5c43)ccc2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.34
▸ ERBB2 P04626 1/20 0.34
▸ FYN P06241 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ AHR P35869 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ HPGD P15428 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ HTT P42858 2/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ HCRTR1 O43613 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ THRB P10828 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ TNKS O95271 1/20 0.32
▸ TNKS2 Q9H2K2 1/20 0.32
▸ ESR1 P03372 1/20 0.31
▸ ESR2 Q92731 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13508012 0.96 CYP1A2 (0.32) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17658014 0.88 ALDH1A1 (0.30) CYP1A2ALDH1A1HPGDTHRBHSD17B10
SCHEMBL17658341 0.88 HPRT1 (0.35) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL17658047 0.88 ALDH1A1 (0.30) CYP1A2ALDH1A1HPGDTHRBHSD17B10
SCHEMBL16153195 0.88 CYP1A1 (0.33) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL13506876 0.86 ESR1 (0.32) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL13508072 0.86 ALDH1A1 (0.37) CYP1A2ALDH1A1HPGDKDM4EHTT
SCHEMBL17658296 0.85 HTT (0.36) ALDH1A1HPGDKDM4EHTTNPSR1
SCHEMBL17658178 0.84 LIMK1 (0.34) ESR1ESR2
SCHEMBL24275568 0.84 NQO1 (0.35) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100032658-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 CYP1A2 780/4885ERBB2 2780/4885FYN 1650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback